Skip to content
Clinical ResearchResearch compound

MENT (Trestolone) – 19‑Nor progestin frame

Experimental steroid developed as a male contraceptive: its progesterone-like effect shuts down sperm production.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

MENT (Trestolone) – 19-Nor progestin frame vial

DETAILED OVERVIEW

What is MENT (Trestolone) – 19-Nor progestin frame?

Trestolone (MENT) is an experimental synthetic steroid belonging to the nandrolone family: a modified version of testosterone that also acts like progesterone. The Population Council developed it as a male contraceptive, but development stalled for financial reasons. It has never been approved as a medicine, today it is sold only on the illegal market, and in Hungary and Poland it is a controlled substance.

This progesterone-like effect is why, in contraceptive studies, sperm production stopped or fell sharply in more than 90% of men; fertility can take months to recover. It also raises the hormone prolactin, which can bring a lower sex drive, erection problems and enlargement of the male breast. It worsens cholesterol values (the good HDL falls) and can cause mood disturbances; in women it causes rapid, largely irreversible masculinization, and in pregnancy it can harm the fetus. WADA bans it year-round. Only a few small studies have been done in humans so far.

Mechanism

19-nor-T derivative with moderate PR affinity + AR agonist (8-10x T); progestogen-mediated HPG suppression

PR affinity (Cook 1996)

Moderate – quasi-progesterone-receptor agonist, contraceptive significance

Anabolic:Androgenic

~2300:650 (extrapolated in vitro AR-binding)

Half-life

~8 h (Ac), 5-7 d (Enan)

Legal status

Never an Rx (Population Council Phase III stalled). UGL only. WADA-banned.

Data console

Lab data

Androgenic:Anabolic650:650
AR bindingExtremely high AR affinity (~8-10x testosterone in vitro…
Active half-life~8 h
Detection windowUrinary: 2-3 weeks (short ester, fast clearance). WADA-accredited LC-MS/MS.
Aromatizationlow
Hepatotoxicitylow

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Deep HPTA suppression and rapid, profound spermatogenesis inhibition (90%+ azoospermia/oligospermia within 4 weeks in trials) – the progestogenic PR-mediated feedback is stronger than with typical androgens, fertility recovery 6–12 months.
  • Elevated prolactin (from PR activity) → lowered libido, erectile dysfunction and prolactin-driven gynecomastia, paradoxically even though aromatization is relatively mild.
  • Adverse lipid profile: moderate-to-marked drop in HDL cholesterol, raising cardiovascular risk during the cycle.
  • Androgenic effects: acne, increased sebum, and scalp hair thinning in predisposed users (it is NOT an 5α-reductase substrate so scalp-DHT is lower, but the high AR affinity keeps it androgenic).
  • Mood and psychiatric disturbances: irritability, anxiety, and depressive episodes in rare case reports (19-nor / progestogen-type effect).
  • Injection-site reaction (PIP, pain, swelling) – stronger with the Acetate ester due to higher mg/ml concentration and frequent EOD/daily dosing, milder with the Enanthate.
  • Mild estrogen-mediated effects (water retention, rise in blood pressure): CYP19 aromatizes it to 7α-methylestradiol with lower ER affinity than plain estradiol, so E2 side effects are milder but not absent.

Contraindications · 7

  • Use by women – the extremely high AR affinity (~8–10x testosterone) causes rapid, partly irreversible virilization (voice deepening, hirsutism, clitoral enlargement).
  • Pregnancy and breastfeeding – androgenic/progestogenic activity carries teratogenic risk (fetal virilization); absolute contraindication.
  • Pre-existing hyperprolactinemia or prolactinoma – the prolactin rise from PR activity can worsen the condition; absolute contraindication.
  • Active or prior hormone-sensitive cancer (prostate, breast carcinoma) – androgenic stimulation may promote progression.
  • Established cardiovascular disease, uncontrolled hypertension or adverse lipid profile – the HDL drop and water retention further worsen the risk.
  • Psychiatric predisposition (depression, anxiety disorder) – the 19-nor/progestogen-type mood effects may trigger or worsen symptoms.
  • Planned near-term fatherhood or need to preserve fertility – recovery after the deep spermatogenesis suppression takes 6–12 months and PCT alone does not sufficiently accelerate it.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about MENT (Trestolone) – 19‑Nor progestin frame?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.